Completed
CTN 289: E/C/F/TAF switch with ledipasivir-sofosbuvir therapy
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
Learn MoreCompleted
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
Learn MoreReporting
Evaluation of web-based interventions to support people living with HIV in the adoption of health behaviours
Learn MoreReporting
Optimizing the delivery of HIV post-exposure prophylaxis: A randomized controlled trial of text messaging support and physician to nurse task-shifting
Learn MoreCompleted
Reporting
The development and validation of a patient-reported measure of antiretroviral therapy’s interference with life: a clinical patient-management tool for healthcare providers
Learn MoreOngoing
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Learn MoreCompleted
Endocrinopathy & cellular aging in women and girls enrolled in the CARMA cohort
Learn MoreCompleted
Motivational Interviewing in Conjunction with Rapid HIV Testing
Learn MoreCTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.